Announced Fri, 26 Jun · 13:31 IST
Trading window closure ahead of Q1 FY27 results
Compliance View source PDF
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.5%1-day move
₹92.50
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.5-4.5-5.9-8.2-10.1-6.8-17.8———
Up moveDown movePending
AI summary
Aarey Drugs has informed exchanges that the trading window for insiders, designated persons and their immediate relatives will be closed from July 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026. This is a routine compliance requirement under SEBI insider trading regulations. The board meeting date to approve the Q1 FY27 results will be intimated later.
Likely market impact
Routine regulatory filing with no direct stock price impact. Signals that Q1 FY27 earnings announcement is expected in the coming weeks.